IL1B and chronic kidney disease: In contrast, the baseline supernatant concentrations of IL-1β secreted from PBMCs were not higher in the HD patients than in the non-CKD individuals (13.17 (1.72–48.40) vs. 39.36 (11.89–79.45) pg/mL, p = 0.081) (Figure 2a).